• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植物和草药治疗糖尿病动脉粥样硬化的叙述性综述:更新与未来展望。

A narrative review of plant and herbal medicines for delaying diabetic atherosclerosis: an update and future perspectives.

机构信息

Department of Pharmacognosy, State Key Laboratory of Natural Medicines, China Pharmaceutical University, 210009 Nanjing, Jiangsu, China.

Department of Pharmacognosy, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 211198 Nanjing, Jiangsu, China.

出版信息

Rev Cardiovasc Med. 2021 Dec 22;22(4):1361-1381. doi: 10.31083/j.rcm2204142.

DOI:10.31083/j.rcm2204142
PMID:34957777
Abstract

Due to their high prevalence and incidence, diabetes and atherosclerosis are increasingly becoming global public health concerns. Atherosclerosis is one of the leading causes of morbidity and disability in type 1 and/or type 2 diabetes patients. Atherosclerosis risk in diabetic patients is obviously higher than that of non-diabetic individuals. Diabetes-related glycolipid metabolism disorder has been shown to play a central role in atherosclerosis development and progression. Hyperglycemia and dyslipidemia increase the risks for atherosclerosis and plaque necrosis through multiple signaling pathways, such as a prolonged increase in reactive oxygen species (ROS) and inflammatory factors in cardiovascular cells. Notwithstanding the great advances in the understanding of the pathologies of diabetes-accelerated atherosclerosis, the current medical treatments for diabetic atherosclerosis hold undesirable side effects. Therefore, there is an urgent demand to identify novel therapeutic targets or alternative strategies to prevent or treat diabetic atherosclerosis. Burgeoning evidence suggests that plant and herbal medicines are closely linked with healthy benefits for diabetic complications, including diabetic atherosclerosis. In this review, we will overview the utilization of plant and herbal medicines for the treatment of diabetes-accelerated atherosclerosis. Furthermore, the underlying mechanisms of the ethnopharmacological therapeutic potentials against diabetic atherosclerosis are gathered and reviewed. It is foreseeable that the natural constituents from medicinal plants might be a new hope for the treatment of diabetes-accelerated atherosclerosis.

摘要

由于糖尿病和动脉粥样硬化的高患病率和发病率,它们日益成为全球公共卫生关注的焦点。动脉粥样硬化是 1 型和/或 2 型糖尿病患者发病和致残的主要原因之一。糖尿病患者的动脉粥样硬化风险明显高于非糖尿病患者。糖尿病相关的糖脂代谢紊乱被证明在动脉粥样硬化的发展和进展中起着核心作用。高血糖和血脂异常通过多种信号通路增加了动脉粥样硬化和斑块坏死的风险,例如心血管细胞中活性氧(ROS)和炎症因子的持续增加。尽管人们对糖尿病加速动脉粥样硬化的病理学有了很大的了解,但目前治疗糖尿病性动脉粥样硬化的医学方法存在不良的副作用。因此,迫切需要确定新的治疗靶点或替代策略来预防或治疗糖尿病性动脉粥样硬化。大量证据表明,植物和草药与糖尿病并发症(包括糖尿病性动脉粥样硬化)的健康益处密切相关。在这篇综述中,我们将概述植物和草药在治疗糖尿病加速动脉粥样硬化中的应用。此外,还收集和综述了这些植物药治疗糖尿病性动脉粥样硬化的潜在机制。可以预见,来自药用植物的天然成分可能为治疗糖尿病加速动脉粥样硬化带来新的希望。

相似文献

1
A narrative review of plant and herbal medicines for delaying diabetic atherosclerosis: an update and future perspectives.植物和草药治疗糖尿病动脉粥样硬化的叙述性综述:更新与未来展望。
Rev Cardiovasc Med. 2021 Dec 22;22(4):1361-1381. doi: 10.31083/j.rcm2204142.
2
Herbal Medicines for Diabetes Management and its Secondary Complications.草药治疗糖尿病及其并发症。
Curr Diabetes Rev. 2021;17(4):437-456. doi: 10.2174/1573399816666201103143225.
3
Management of diabetic complications: a chemical constituents based approach.糖尿病并发症的管理:基于化学成分的方法。
J Ethnopharmacol. 2013 Oct 28;150(1):51-70. doi: 10.1016/j.jep.2013.08.051. Epub 2013 Sep 13.
4
Cellular and Molecular Mechanisms of Diabetic Atherosclerosis: Herbal Medicines as a Potential Therapeutic Approach.糖尿病性动脉粥样硬化的细胞和分子机制:草药作为一种潜在的治疗方法。
Oxid Med Cell Longev. 2017;2017:9080869. doi: 10.1155/2017/9080869. Epub 2017 Aug 13.
5
Effects of High Intensity Statin Therapy in the Treatment of Diabetic Dyslipidemia in Patients with Coronary Artery Disease.高强度他汀类药物治疗对冠心病合并糖尿病血脂异常患者的影响。
Curr Pharm Des. 2018;24(4):427-441. doi: 10.2174/1381612824666171227215708.
6
The application of metabolomics in investigating anti-diabetic activity of medicinal plants.代谢组学在研究药用植物抗糖尿病活性中的应用。
Biomed Pharmacother. 2020 Aug;128:110263. doi: 10.1016/j.biopha.2020.110263. Epub 2020 May 22.
7
[Diabetic dyslipidaemia and the atherosclerosis].[糖尿病血脂异常与动脉粥样硬化]
Orv Hetil. 2016 May 8;157(19):746-52. doi: 10.1556/650.2016.30441.
8
The nuances of atherogenic dyslipidemia in diabetes: focus on triglycerides and current management strategies.糖尿病中致动脉粥样硬化性血脂异常的细微差别:关注甘油三酯及当前管理策略
Indian Heart J. 2013 Dec;65(6):683-90. doi: 10.1016/j.ihj.2013.10.015. Epub 2013 Nov 25.
9
Pharmacologic therapy for coronary atherosclerosis in patients with Type 2 diabetes mellitus.2型糖尿病患者冠状动脉粥样硬化的药物治疗
Expert Rev Cardiovasc Ther. 2009 Jan;7(1):85-93. doi: 10.1586/14779072.7.1.85.
10
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes.2 型糖尿病患者降脂治疗的新治疗选择。
Acta Diabetol. 2018 Mar;55(3):209-218. doi: 10.1007/s00592-017-1089-4. Epub 2017 Dec 19.

引用本文的文献

1
Heqi San alleviates diabetic atherosclerosis and alters serum metabolic profiles in rats.和剂散减轻大鼠糖尿病性动脉粥样硬化并改变血清代谢谱。
BMC Cardiovasc Disord. 2025 Aug 18;25(1):610. doi: 10.1186/s12872-025-05012-z.
2
The novel role of Aiton extracts as antidiabetic and anti-inflammatory functions in pancreatic Β cells exposed to hyperglycaemia.艾顿提取物在暴露于高血糖环境的胰腺β细胞中作为具有抗糖尿病和抗炎功能的新作用。
J Diabetes Metab Disord. 2025 Jun 2;24(1):136. doi: 10.1007/s40200-025-01654-0. eCollection 2025 Jun.
3
Ameliorates Carbohydrate and Lipid Metabolism Disorders in Diabetic Mice by Regulating Bile Acid Metabolism via the Gut-Liver Axis.
通过肠道-肝脏轴调节胆汁酸代谢改善糖尿病小鼠的碳水化合物和脂质代谢紊乱
Pharmaceuticals (Basel). 2024 Aug 1;17(8):1015. doi: 10.3390/ph17081015.
4
Glycolipid Metabolic Disorders, Metainflammation, Oxidative Stress, and Cardiovascular Diseases: Unraveling Pathways.糖脂代谢紊乱、代谢性炎症、氧化应激与心血管疾病:解析相关通路
Biology (Basel). 2024 Jul 12;13(7):519. doi: 10.3390/biology13070519.
5
Deficiency of neutral cholesterol ester hydrolase 1 (NCEH1) impairs endothelial function in diet-induced diabetic mice.缺乏中性胆固醇酯水解酶 1(NCEH1)可损害饮食诱导的糖尿病小鼠的内皮功能。
Cardiovasc Diabetol. 2024 Apr 25;23(1):138. doi: 10.1186/s12933-024-02239-6.
6
Metrnl ameliorates diabetic cardiomyopathy via inactivation of cGAS/STING signaling dependent on LKB1/AMPK/ULK1-mediated autophagy.Metrnl 通过依赖于 LKB1/AMPK/ULK1 介导的自噬的 cGAS/STING 信号失活来改善糖尿病心肌病。
J Adv Res. 2023 Sep;51:161-179. doi: 10.1016/j.jare.2022.10.014. Epub 2022 Nov 9.
7
A dual Keap1 and p47 inhibitor Ginsenoside Rb1 ameliorates high glucose/ox-LDL-induced endothelial cell injury and atherosclerosis.一种双重 Keap1 和 p47 抑制剂——人参皂苷 Rb1 可改善高糖/氧化型低密度脂蛋白诱导的内皮细胞损伤和动脉粥样硬化。
Cell Death Dis. 2022 Sep 26;13(9):824. doi: 10.1038/s41419-022-05274-x.